Hantz Financial Services’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$74K Buy
264
+89
+51% +$23.4K ﹤0.01% 1504
2026
Q1
$47K Buy
175
+39
+29% +$10.6K ﹤0.01% 1582
2025
Q4
$34K Buy
136
+14
+11% +$3.72K ﹤0.01% 1581
2025
Q3
$35K Buy
122
+40
+49% +$10.7K ﹤0.01% 1357
2025
Q2
$22K Buy
82
+72
+720% +$17.5K ﹤0.01% 1228
2025
Q1
$2K Sell
10
-40
-80% -$9.71K ﹤0.01% 1389
2024
Q4
$11K Buy
50
+42
+525% +$9.63K ﹤0.01% 803
2024
Q3
$2K Hold
8
﹤0.01% 966
2024
Q2
$2K Hold
8
﹤0.01% 957
2024
Q1
$2K Hold
8
﹤0.01% 1067
2023
Q4
$2K Hold
8
﹤0.01% 1030
2023
Q3
$2K Sell
8
-1
-11% -$211 ﹤0.01% 1022
2023
Q2
$2K Hold
9
﹤0.01% 991
2023
Q1
$2K Sell
9
-93
-91% -$19.1K ﹤0.01% 998
2022
Q4
$21K Buy
102
+93
+1,033% +$18.2K ﹤0.01% 672
2022
Q3
$2K Hold
9
﹤0.01% 966
2022
Q2
$2K Buy
+9
New +$1.92K ﹤0.01% 938

Other funds holding LH

Hantz Financial Services's LH Position: Q2 2026 in Review

Hantz Financial Services increased its Labcorp (LH) stake by 51% in Q2 2026, buying an estimated $23.4K and bringing the position to 264 shares worth $74K. The position accounts for ﹤0.01% of the portfolio, ranked #1504.

Hantz Financial Services first reported a position in LH in Q2 2022 and has held it in 17 quarters since. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Hantz Financial Services held 264 shares of Labcorp worth $74K as of Q2 2026.
  • Hantz Financial Services bought 89 Labcorp shares in Q2 2026, an estimated $23.4K.
  • Labcorp made up ﹤0.01% of Hantz Financial Services's portfolio in Q2 2026, its #1504 holding.
  • Hantz Financial Services first reported a position in Labcorp in Q2 2022 and has held it in 17 quarters since.
  • 1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.